Amdocs Average Equity vs Invested Capital Average Analysis
DOX Stock | USD 84.82 0.22 0.26% |
Trend analysis of Amdocs balance sheet accounts such as Other Current Liabilities of 1 B or Total Current Liabilities of 1 B provides information on Amdocs' total assets, liabilities, and equity, which is the actual value of Amdocs to its prevalent stockholders. By breaking down trends over time using Amdocs balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Amdocs |
About Amdocs Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Amdocs at a specified time, usually calculated after every quarter, six months, or one year. Amdocs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Amdocs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Amdocs currently owns. An asset can also be divided into two categories, current and non-current.
Amdocs Balance Sheet Chart
Amdocs Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Amdocs uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Amdocs' Non Current Liabilities Total is fairly stable compared to the past year. Other Current Assets is likely to rise to about 307 M in 2024, whereas Total Assets are likely to drop slightly above 4.5 B in 2024. Add Fundamental
Total Assets
Total assets refers to the total amount of Amdocs assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Amdocs books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Amdocs balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Amdocs are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most indicators from Amdocs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amdocs current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.At this time, Amdocs' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 14.45 in 2024, whereas Selling General Administrative is likely to drop slightly above 390.6 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.6B | 1.7B | 2.0B | 1.1B | Total Revenue | 4.6B | 4.9B | 5.6B | 3.1B |
Amdocs fundamental ratios Correlations
Click cells to compare fundamentals
Amdocs Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Amdocs fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.3B | 6.5B | 6.4B | 6.4B | 7.4B | 4.5B | |
Other Current Liab | 794.4M | 886.6M | 821.3M | 849.4M | 976.9M | 1.0B | |
Total Current Liabilities | 1.2B | 1.3B | 1.3B | 1.4B | 1.6B | 1.0B | |
Total Stockholder Equity | 3.6B | 3.6B | 3.5B | 3.5B | 4.1B | 2.8B | |
Property Plant And Equipment Net | 903.4M | 931.9M | 971.2M | 951.9M | 1.1B | 1.1B | |
Net Debt | 50.0M | 172.1M | 253.5M | 287.2M | 258.5M | 271.4M | |
Retained Earnings | 5.3B | 5.9B | 6.2B | 6.5B | 7.5B | 7.9B | |
Accounts Payable | 930.3M | 121.2M | 134.4M | 293.3M | 337.3M | 428.4M | |
Cash | 983.2M | 709.1M | 573.4M | 520.1M | 598.1M | 720.1M | |
Non Current Assets Total | 4.3B | 4.4B | 4.4B | 4.5B | 5.2B | 2.6B | |
Non Currrent Assets Other | 488.6M | 630.7M | 574.9M | 631.6M | 726.3M | 762.6M | |
Cash And Short Term Investments | 983.9M | 965.6M | 818.0M | 742.5M | 853.9M | 1.0B | |
Net Receivables | 861.0M | 866.8M | 946.8M | 944.5M | 1.1B | 618.6M | |
Common Stock Shares Outstanding | 133.2M | 128.0M | 121.9M | 118.5M | 106.6M | 144.3M | |
Liabilities And Stockholders Equity | 6.3B | 6.5B | 6.4B | 6.4B | 7.4B | 4.5B | |
Non Current Liabilities Total | 1.5B | 1.6B | 1.6B | 1.5B | 1.7B | 1.8B | |
Other Current Assets | 229.6M | 235.1M | 238.4M | 224.6M | 258.3M | 307.0M | |
Other Stockholder Equity | (1.7B) | (2.3B) | (2.6B) | (3.0B) | (2.7B) | (2.5B) | |
Total Liab | 2.7B | 2.9B | 2.8B | 2.9B | 3.3B | 1.7B | |
Total Current Assets | 2.1B | 2.1B | 2.0B | 1.9B | 2.2B | 1.9B | |
Short Term Debt | 159.1M | 58.7M | 43.3M | 40.0M | 46.0M | 43.7M | |
Property Plant And Equipment Gross | 903.4M | 931.9M | 971.2M | 951.9M | 1.1B | 1.1B | |
Accumulated Other Comprehensive Income | 11.7M | 9.3M | (72.5M) | (53.3M) | (47.9M) | (45.5M) | |
Common Stock | 4.5M | 4.5M | 4.5M | 4.6M | 5.3M | 4.4M | |
Current Deferred Revenue | 126.8M | 237.4M | 253.7M | 170.6M | 196.2M | 184.3M | |
Other Liab | 542.4M | 586.2M | 750.3M | 793.9M | 913.0M | 469.4M | |
Other Assets | 423.9M | 488.6M | 630.7M | 574.9M | 661.2M | 386.6M | |
Good Will | 2.6B | 2.6B | 2.7B | 2.7B | 3.2B | 1.9B | |
Intangible Assets | 296.3M | 259.0M | 178.3M | 181.5M | 163.4M | 317.6M | |
Property Plant Equipment | 354.0M | 723.6M | 931.9M | 971.2M | 1.1B | 1.2B | |
Short Term Investments | 752K | 256.5M | 244.6M | 222.5M | 200.2M | 266.3M | |
Net Tangible Assets | 660.6M | 567.8M | 711.0M | 676.6M | 609.0M | 676.1M |
Pair Trading with Amdocs
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.Moving against Amdocs Stock
0.67 | EGIO | Edgio Inc Tech Boost | PairCorr |
0.64 | NN | Nextnav Acquisition Corp Upward Rally | PairCorr |
0.58 | VERI | Veritone Financial Report 7th of May 2024 | PairCorr |
0.55 | GB | Global Blue Group | PairCorr |
The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Amdocs Stock analysis
When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Transaction History View history of all your transactions and understand their impact on performance |
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.18 | Dividend Share 1.74 | Earnings Share 4.68 | Revenue Per Share 41.665 | Quarterly Revenue Growth 0.05 |
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.